Rapid Microbiology Testing Market Size was valued at USD 4.7 Bn in 2023 and is predicted to reach USD 10.4 Bn by 2031 at a 10.7% CAGR during the forecast period for 2024-2031.
The rapid microbiology testing market is experiencing rapid growth driven by technological advancements. This growth is particularly evident in industries such as pharmaceuticals, cosmetics, municipal water, and food and beverage, where microbiological testing plays a critical role in ensuring product safety and regulatory compliance. These products are cost-effective and can often lead to cost savings compared to traditional methods, a significant factor driving their uptake. Continuous technological advancements improve their sensitivity and specificity, making them more competitive. Moreover, the COVID-19 pandemic has accelerated the adoption of rapid microbiology testing solutions, with many companies developing rapid antigen tests and molecular assays for SARS-CoV-2 detection.
Potential risks include regulatory hurdles for approval, concerns regarding the accuracy and reliability of rapid tests compared to traditional methods, and the need for standardization and validation across different pathogens and sample types. Despite these challenges, the rapid microbiology testing market is poised for substantial growth, driven by technological advancements, increasing demand for faster diagnostic solutions, and the ongoing need for efficient microbial monitoring across various industries.
The rapid microbiology testing market is segmented into product, application, and method. The segmentation is based on products, including instruments, reagents and kits, and consumables. By application, the market is segmented into clinical disease diagnosis, industrial testing, and research. By method the market is segmented into growth-based rapid microbiology testing, cellular component-based rapid microbiology testing, nucleic acid-based rapid microbiology testing, viability-based rapid microbiology diagnostic testing, other rapid microbiology testing method.
The reagents and kits segment is a major contributor to the rapid microbiology testing market. These products are vital components for conducting rapid microbiology tests, providing the necessary reagents and materials for sample preparation, detection, and analysis. Reagents and kits offer convenience and efficiency, enabling laboratories and healthcare facilities to quickly perform microbial tests without the need for extensive manual preparation.
Food and beverage testing segment is experiencing rapid growth in the rapid microbiology testing market. Stringent regulations, consumer demand for safe products, and increasing awareness of foodborne illnesses drive this. Rapid microbiology tests offer quick and reliable detection of pathogens and spoilage organisms in food and beverages, ensuring product safety and quality. Additionally, technological advancements such as PCR-based methods and biosensors enhance the speed and accuracy of testing, further fueling market growth. As food safety regulations become stricter worldwide and consumer preferences shift towards healthier and safer products, the demand for rapid microbiology testing in the food and beverage industry is expected to continue rising rapidly.
In the rapid microbiology testing market, North America stands tall, holding a significant revenue share. This is not by chance, but due to factors such as a well-established healthcare infrastructure, stringent regulatory standards, and a high prevalence of infectious diseases. The region's advanced technological capabilities and strong presence of key market players further contribute to its dominance. This stability and growth in North America's market should instill confidence in stakeholders about the market's future.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 4.7 Bn |
|
Revenue Forecast In 2031 |
USD 10.4 Bn |
|
Growth Rate CAGR |
CAGR of 10.7% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Application, By Method and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Abbott, BD, BioMerieux SA, Bruker, Charles River, Danaher, Don Whitley Scientific Limited, Merck KGaA, Neogen Corporation, Quidel Corporation, Rapid Micro Biosystems, Inc., Sartorius Group, Thermo Fisher Scientific, TSI, Vivione Biosciences Inc., ERBA Diagnostics, Vedalab, Rtalabs, Shimadzu Corporation, Pall Corporation. and Mocon, Inc. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Rapid Microbiology Testing Market Snapshot
Chapter 4. Global Rapid Microbiology Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Estimates & Trend Analysis
5.1. by Product & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product:
5.2.1. Instruments
5.2.1.1. Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems
5.2.1.2. Mass Spectrometers
5.2.1.3. PCR Systems
5.2.1.4. Bioluminescence & Fluorescence-based Detection Systems
5.2.1.5. Cytometers
5.2.1.6. Active Air Samplers
5.2.1.7. Other Instruments
5.2.2. Reagents & Kits
5.2.2.1. Sterility Testing Reagents & Kits
5.2.2.2. Other Reagents & Kits
5.2.3. Consumables
Chapter 6. Market Segmentation 2: by Method Estimates & Trend Analysis
6.1. by Method & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Method:
6.2.1. Growth-based Rapid Microbiology Testing
6.2.2. Cellular Component-based Rapid Microbiology Testing
6.2.3. Nucleic Acid-based Rapid Microbiology Testing
6.2.4. Viability-based Rapid Microbiology Testing
6.2.5. Other Rapid Microbiology Testing Methods
Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis
7.1. by Application & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
7.2.1. Clinical Disease Diagnosis
7.2.2. Industrial Testing
7.2.2.1. Food & Beverage Testing
7.2.2.2. Pharmaceutical & Biological Drug Testing
7.2.2.3. Environmental Testing
7.2.2.4. Cosmetics & Personal Care Products Testing
7.2.2.5. Other Industrial Testing Applications
7.2.3. Research Applications
Chapter 8. Rapid Microbiology Testing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.1.2. North America Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Method, 2019-2031
8.1.3. North America Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.1.4. North America Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.2.2. Europe Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Method, 2019-2031
8.2.3. Europe Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.2.4. Europe Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.3.2. Asia Pacific Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Method, 2019-2031
8.3.3. Asia-Pacific Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.3.4. Asia Pacific Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.4.2. Latin America Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Method, 2019-2031
8.4.3. Latin America Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.4.4. Latin America Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.5.2. Middle East & Africa Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Method, 2019-2031
8.5.3. Middle East & Africa Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.5.4. Middle East & Africa Rapid Microbiology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Abbott
9.2.2. BD
9.2.3. BioMerieux SA
9.2.4. Bruker
9.2.5. Charles River
9.2.6. Danaher
9.2.7. Don Whitley Scientific Limited
9.2.8. Merck KGaA
9.2.9. Neogen Corporation
9.2.10. Quidel Corporation
9.2.11. Rapid Micro Biosystems, Inc.
9.2.12. Sartorius Group
9.2.13. Thermo Fisher Scientific
9.2.14. TSI
9.2.15. Vivione Biosciences Inc.
9.2.16. ERBA Diagnostics
9.2.17. Vedalab
9.2.18. Rtalabs
9.2.19. Shimadzu Corporation.
9.2.20. Pall Corporation.
9.2.21. Mocon, Inc
9.2.22. Other Prominent Players
Rapid Microbiology Testing Market- By Product
Rapid Microbiology Testing Market- By Application
Rapid Microbiology Testing Market- By Method
Rapid Microbiology Testing Market- By Region
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
